UBS AM’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.4M | Sell |
1,653,714
-58,645
| -3% | -$1.63M | 0.01% | 675 |
|
|
2025
Q4 | $47.5M | Buy |
1,712,359
+46,974
| +3% | +$1.2M | 0.01% | 616 |
|
|
2025
Q3 | $40.4M | Buy |
1,665,385
+1,171,977
| +238% | +$23.3M | 0.01% | 643 |
|
|
2025
Q2 | $8.39M | Buy |
493,408
+54,879
| +13% | +$956K | ﹤0.01% | 1450 |
|
|
2025
Q1 | $8.56M | Buy |
438,529
+42,609
| +11% | +$1.12M | ﹤0.01% | 1297 |
|
|
2024
Q4 | $9.82M | Sell |
395,920
-5,366
| -1% | -$137K | ﹤0.01% | 1254 |
|
|
2024
Q3 | $9.83M | Sell |
401,286
-18,283
| -4% | -$472K | ﹤0.01% | 1232 |
|
|
2024
Q2 | $9.83M | Buy |
419,569
+121,223
| +41% | +$2.98M | ﹤0.01% | 1146 |
|
|
2024
Q1 | $9.86M | Sell |
298,346
-7,385
| -2% | -$230K | ﹤0.01% | 1007 |
|
|
2023
Q4 | $8.32M | Buy |
305,731
+25,576
| +9% | +$635K | ﹤0.01% | 1060 |
|
|
2023
Q3 | $6.74M | Buy |
280,155
+44,132
| +19% | +$1.18M | ﹤0.01% | 1105 |
|
|
2023
Q2 | $7.23M | Hold |
236,023
| – | – | ﹤0.01% | 1086 |
|
|
2023
Q1 | $7.23M | Sell |
236,023
-12,480
| -5% | -$493K | ﹤0.01% | 1086 |
|
|
2022
Q4 | $9.72M | Buy |
248,503
+189,713
| +323% | +$8.5M | 0.01% | 949 |
|
|
2022
Q3 | $2.8M | Sell |
58,790
-6,578
| -10% | -$375K | ﹤0.01% | 1425 |
|
|
2022
Q2 | $2.53M | Buy |
65,368
+20,591
| +46% | +$818K | ﹤0.01% | 1517 |
|
|
2022
Q1 | $2.57M | Buy |
44,777
+4,317
| +11% | +$283K | ﹤0.01% | 1668 |
|
|
2021
Q4 | $3.22M | Buy |
40,460
+820
| +2% | +$70.2K | ﹤0.01% | 1627 |
|
|
2021
Q3 | $3.45M | Buy |
39,640
+1,896
| +5% | +$190K | ﹤0.01% | 1545 |
|
|
2021
Q2 | $4.86M | Buy |
37,744
+19,593
| +108% | +$1.56M | ﹤0.01% | 1380 |
|
|
2021
Q1 | $1.45M | Buy |
18,151
+5,113
| +39% | +$486K | ﹤0.01% | 1902 |
|
|
2020
Q4 | $1.06M | Buy |
+13,038
| New | +$641K | ﹤0.01% | 1956 |
|
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
